1. Home
  2. CMPX vs GES Comparison

CMPX vs GES Comparison

Compare CMPX & GES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMPX
  • GES
  • Stock Information
  • Founded
  • CMPX 2014
  • GES 1981
  • Country
  • CMPX United States
  • GES Switzerland
  • Employees
  • CMPX N/A
  • GES N/A
  • Industry
  • CMPX Biotechnology: Pharmaceutical Preparations
  • GES Apparel
  • Sector
  • CMPX Health Care
  • GES Consumer Discretionary
  • Exchange
  • CMPX Nasdaq
  • GES Nasdaq
  • Market Cap
  • CMPX 730.9M
  • GES 872.4M
  • IPO Year
  • CMPX N/A
  • GES 1996
  • Fundamental
  • Price
  • CMPX $4.03
  • GES $16.93
  • Analyst Decision
  • CMPX Strong Buy
  • GES Buy
  • Analyst Count
  • CMPX 7
  • GES 5
  • Target Price
  • CMPX $14.71
  • GES $19.25
  • AVG Volume (30 Days)
  • CMPX 1.9M
  • GES 602.2K
  • Earning Date
  • CMPX 11-11-2025
  • GES 11-25-2025
  • Dividend Yield
  • CMPX N/A
  • GES 5.34%
  • EPS Growth
  • CMPX N/A
  • GES N/A
  • EPS
  • CMPX N/A
  • GES 0.35
  • Revenue
  • CMPX N/A
  • GES $3,091,508,000.00
  • Revenue This Year
  • CMPX N/A
  • GES $7.97
  • Revenue Next Year
  • CMPX N/A
  • GES $3.46
  • P/E Ratio
  • CMPX N/A
  • GES $48.87
  • Revenue Growth
  • CMPX N/A
  • GES 7.84
  • 52 Week Low
  • CMPX $1.27
  • GES $8.48
  • 52 Week High
  • CMPX $4.86
  • GES $18.08
  • Technical
  • Relative Strength Index (RSI)
  • CMPX 53.07
  • GES 66.58
  • Support Level
  • CMPX $3.86
  • GES $16.75
  • Resistance Level
  • CMPX $4.86
  • GES $16.89
  • Average True Range (ATR)
  • CMPX 0.31
  • GES 0.09
  • MACD
  • CMPX -0.05
  • GES -0.05
  • Stochastic Oscillator
  • CMPX 38.43
  • GES 95.00

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.

About GES Guess? Inc.

Guess? Inc designs, markets distributes, and licenses contemporary apparel and accessories that reflect European fashion sensibilities and American Lifestyle under brands including Guess, Marciano, and G by Guess. The company has five reportable segments: Americas Retail, Americas Wholesale, Europe, Asia, and licensing. Geographically, the company derives maximum revenue from the United States.

Share on Social Networks: